Literature DB >> 21708875

Relationship between central and peripheral atherosclerosis and left ventricular dysfunction in a community population.

Connie W Tsao1, Philimon Gona, Carol Salton, Joanne M Murabito, Noriko Oyama, Peter G Danias, Christopher J O'Donnell, Warren J Manning, Susan B Yeon.   

Abstract

We aimed to determine the relationships between resting left ventricular (LV) wall motion abnormalities (WMAs), aortic plaque, and peripheral artery disease (PAD) in a community cohort. A total of 1726 Framingham Heart Study Offspring Cohort participants (806 males, 65 ± 9 years) underwent cardiovascular magnetic resonance with quantification of aortic plaque volume and assessment of regional left ventricular systolic function. Claudication, lower extremity revascularization, and ankle-brachial index (ABI) were recorded at the most contemporaneous examination visit. WMAs were associated with greater aortic plaque burden, decreased ABI, and claudication in age- and sex-adjusted analyses (all p < 0.001), which were not significant after adjustment for cardiovascular risk factors. In age- and sex-adjusted analyses, both the presence (p < 0.001) and volume of aortic plaque were associated with decreased ABI (p < 0.001). After multivariable adjustment, an ABI ≤ 0.9 or prior revascularization was associated with a threefold odds of aortic plaque (p = 0.0083). Plaque volume significantly increased with decreasing ABI in multivariable-adjusted analyses (p < 0.0001). In this free-living population, associations of WMAs with aortic plaque burden and clinical measures of PAD were attenuated after adjustment for coronary heart disease risk factors. Aortic plaque volume and ABI remained strongly negatively correlated after multivariable adjustment. Our findings suggest that the association between coronary heart disease and non-coronary atherosclerosis is explained by cardiovascular risk factors. Aortic atherosclerosis and PAD remain strongly associated after multivariable adjustment, suggesting shared mechanisms beyond those captured by traditional risk factors.

Entities:  

Mesh:

Year:  2011        PMID: 21708875      PMCID: PMC3249244          DOI: 10.1177/1358863X11408640

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  30 in total

Review 1.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

2.  Calcification of the aortic arch: risk factors and association with coronary heart disease, stroke, and peripheral vascular disease.

Authors:  C Iribarren; S Sidney; B Sternfeld; W S Browner
Journal:  JAMA       Date:  2000-06-07       Impact factor: 56.272

3.  Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study.

Authors:  Joanne M Murabito; Jane C Evans; Kenneth Nieto; Martin G Larson; Daniel Levy; Peter W f Wilson
Journal:  Am Heart J       Date:  2002-06       Impact factor: 4.749

4.  Carotid artery plaque burden, stiffness, and mortality risk in elderly men: a prospective, population-based cohort study.

Authors:  Stefan Störk; Annewieke W van den Beld; Clemens von Schacky; Christiane E Angermann; Steven W J Lamberts; Diederick E Grobbee; Michiel L Bots
Journal:  Circulation       Date:  2004-07-06       Impact factor: 29.690

5.  Prognostic significance of regional wall motion abnormality in patients with prior myocardial infarction: a prospective correlative study of two-dimensional echocardiography and angiography.

Authors:  A Shiina; A J Tajik; H C Smith; M Lengyel; J B Seward
Journal:  Mayo Clin Proc       Date:  1986-04       Impact factor: 7.616

6.  Gender differences and normal left ventricular anatomy in an adult population free of hypertension. A cardiovascular magnetic resonance study of the Framingham Heart Study Offspring cohort.

Authors:  Carol J Salton; Michael L Chuang; Christopher J O'Donnell; Michelle J Kupka; Martin G Larson; Kraig V Kissinger; Robert R Edelman; Daniel Levy; Warren J Manning
Journal:  J Am Coll Cardiol       Date:  2002-03-20       Impact factor: 24.094

7.  Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study.

Authors:  Helaine E Resnick; Robert S Lindsay; Mary McGrae McDermott; Richard B Devereux; Kristina L Jones; Richard R Fabsitz; Barbara V Howard
Journal:  Circulation       Date:  2004-02-17       Impact factor: 29.690

8.  Segmental wall motion abnormalities in idiopathic dilated cardiomyopathy and their effect on prognosis.

Authors:  Laurent Fauchier; Veronique Eder; Danielle Casset-Senon; Olivier Marie; Dominique Babuty; Pierre Cosnay; Jean Paul Fauchier
Journal:  Am J Cardiol       Date:  2004-06-15       Impact factor: 2.778

9.  Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography.

Authors:  J C C Moon; N G Fisher; W J McKenna; D J Pennell
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

10.  Calcification of the thoracic aorta as detected by spiral computed tomography among stable angina pectoris patients: association with cardiovascular events and death.

Authors:  Alon Eisen; Alexander Tenenbaum; Nira Koren-Morag; David Tanne; Joseph Shemesh; Massimo Imazio; Enrique Z Fisman; Michael Motro; Ehud Schwammenthal; Yehuda Adler
Journal:  Circulation       Date:  2008-09-08       Impact factor: 29.690

View more
  1 in total

1.  Prevalence of lower extremities peripheral arterial disease among Egyptian ischemic patients attending cardiac rehabilitation unit.

Authors:  Mohamed Waheed Basyouni; Adel Mohamed Shabana; Wael Mahmoud El Kilani
Journal:  Egypt Heart J       Date:  2018-06-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.